Case Report
Published on 30 Jun 2025
Case Report: Subcutaneous ofatumumab for patients with immunosuppressant-dependent or ineffective primary membranous nephropathy
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
- 345 views